Nanotechnology has been a promising therapeutic and scientific approach to effectively
deal in healthcare with a potential to bring significant improvements in disease diagnosis
and management. The existing drug regimen has become increasingly effective with the use of
nanomedicines against many dreadful diseases especially AIDS. Nanomedicines have shown
promising attributes such as slow and sustained release, nominal side effects, low toxicity, and
increased concentration of the drug at the target site along with increased life-span of the drug.
Still many challenges persist with regard to effective diagnosis and management of HIV infected
patients considering the severity and complexity of the disease. The need is to develop
effective nano-based regimens to diagnose, treat and manage AIDS by significantly improving
the patient compliance along with reduced dosage frequency. The current review article has
been designed to effectively address the state-of-the-art drug delivery strategies being implicated
in the field of nanomedicine which could provide a better alternative for the existing HIV
drug regimens offering more specificity, biocompatibility and biodegradability.
Keywords: AIDS, HIV, nanocarriers, nanoformulation, nanoparticles, nanotechnology, targeted delivery.
Rights & PermissionsPrintExport